摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[5-[4-[[4-(1-Methylethoxy)phenyl]sulfonyl]-1-piperazinyl]-2-(5-methyl-1,3,4-thiadiazol-2-yl)phenoxy]acetic acid | 932372-02-6

中文名称
——
中文别名
——
英文名称
2-[5-[4-[[4-(1-Methylethoxy)phenyl]sulfonyl]-1-piperazinyl]-2-(5-methyl-1,3,4-thiadiazol-2-yl)phenoxy]acetic acid
英文别名
2-[2-(5-methyl-1,3,4-thiadiazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]acetic acid
2-[5-[4-[[4-(1-Methylethoxy)phenyl]sulfonyl]-1-piperazinyl]-2-(5-methyl-1,3,4-thiadiazol-2-yl)phenoxy]acetic acid化学式
CAS
932372-02-6
化学式
C24H28N4O6S2
mdl
——
分子量
532.642
InChiKey
FXIVHOSCWGHDMS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    159
  • 氢给体数:
    1
  • 氢受体数:
    11

文献信息

  • SULFONAMIDE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONISTIC ACTIVITY
    申请人:SHIONOGI & CO., LTD.
    公开号:US20150158833A1
    公开(公告)日:2015-06-11
    The present invention provides an sulfonamide derivative having DP receptor antagonistic activity and a pharmaceutical composition comprising the said compound as an active ingredient, and further a therapeutic agent for treating allergic diseases. A compound of the general formula (II): wherein the ring A is an aromatic carbocyclic ring etc.; the ring B is a nitrogen-containing non-aromatic heterocyclic ring etc.; the ring C is an aromatic carbocyclic ring etc.; R1 is carboxy etc.; R2 is independently a halogen atom etc.; R3 is optionally substituted alkyloxy etc.; R4 is independently a halogen atom etc.; R5 is independently optionally substituted alkyl etc.; M is sulfonyl etc.; Y is a single bond etc.; L1 is a single bond etc.; L2 is a single bond etc.; k is 0, 1, 2, 3 or 4; n is 0, 1 or 2; and q is 0, 1, 2 or 3; provided that a) k is not 0 when the ring B is a 6-membered nitrogen-containing heterocyclic ring containing one or two nitrogen atom(s) and the ring C is a benzene ring, etc.; a pharmaceutically acceptable salt or a hydrate thereof.
  • US9440938B2
    申请人:——
    公开号:US9440938B2
    公开(公告)日:2016-09-13
查看更多